Meprednisone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H28O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67U96J8P35, chemically known as 17, 21-dihydroxy-16.beta.-methylpregna-1,4-diene-3,11,20-trione but generally known as meprednisone, which bears US NIH Compound Identifier 4063. European Medicines Agency schedules Meprednisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08756MIG. The term MEPREDNISONE is an International Non-Proprietary Name. World Health Organization schedules meprednisone in its Anatomical Therapeutic Chemical (ATC) Classification. MEPREDNISONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule meprednisone under HS 29372900 and SITC 54153. As of Q4 2014, MEPREDNISONE remains the US FDA Preferred Term for this commodity. Meprednisone bears US NLM identifiers UMLS ID C0065967 and NCI Concept Code C66096. SMILES: OC1(C2(C(C3C(C4(C(=CC(=O)C=C4)CC3)C)C(=O)C2)CC1C)C)C(=O)CO.